The Use of Alternative Anti-Coagulation Strategies for a Nocturnal Home Hemodialysis Patient with Heparin-Induced Thrombocytopenia (Clinical Report)
CANNT Journal 2008, Oct-Dec, 18, 4
-
- $5.99
-
- $5.99
Publisher Description
********** The use of heparin as the anticoagulant of choice for the prevention of extracorporeal blood clotting has been a mainstay since the inception of hemodialysis treatments. For individuals who hemodialyze themselves at home overnight on nocturnal home dialysis (NHD), anticoagulation is a fundamental and essential component of the treatment. If the patient is unable to use heparin, outcomes could potentially be catastrophic, and may lead to treatment failure, thus, alternatives must be considered.
Conversion from Epoetin Alfa to Darbepoetin Alfa Within the Manitoba Renal Program: Evaluation of Dose Ratios.
2008
Impact of Single-Needle Therapy in New Chronic Hemodialysis Starts for Individuals with Arteriovenous Fistulae (Report)
2009
Ontario Formulary
2005
Are CSN and NKF-K/DOQI Mineral Metabolism Guidelines for Hemodialysis Patients Achievable? Results from a Provincial Renal Program (Continuing EDUCATION Series) (Canadian Society of Nephrology) (National Kidney Foundation's Kidney Disease Outcomes Quality Initiative)
2008
Preventing Substitution Errors Involving High-Concentration Heparin Products (ISMP Canada)
2008
Long-Term Soliris Treatment Improves Kidney Function
2010
Chronic Kidney Disease: What's in a Name?
2009
An Update on the Treatment and Management of Diabetic Peripheral Neuropathy (Continuing EDUCATION SERIES)
2006
Compliance, Adherence, And Self-Management: Is a Paradigm Shift Possible for Chronic Kidney Disease Clients?
2006
Conservative Management of End Stage Renal Disease and Withdrawal of Dialysis (Disease/Disorder Overview)
2010
Reflecting on 14 Years of Nocturnal Home Hemodialysis in Canada (1990S)
2008
Initiation of Hemodialysis on an Infant with End Stage Renal Disease--a Nursing Perspective (1980S) (Case Study)
2008